-The proposal made by the Minister of Health to award the procurement for the purchase of 85,000 vials of Concentrated Monoclonal Purified and Detergent Treated Dried Factor VIII Fraction 200 IU - 350 IU which is being used to treat Haemophilia patients for the year 2021, to M/s Baxalta GmbH, Switzerland at a sum of US$ 5.185 million with the total cost and freight, as recommended by the Standing Cabinet Appointed Procurement Committee, was approved by the Cabinet.